MedNet to introduce SaaS EDC to speed trial set up

By Nick Taylor

- Last updated on GMT

Related tags: Contract research organization

MedNet Solutions is introducing iMedNet, a pay-as-you-go web-based EDC platform to support collaboration and communication between clinical trial stakeholders.

The company is the latest to signal intent to enter the increasingly populated market for software-as-a-service (SaaS) clinical trial systems. MedNet believes its electronic data capture (EDC) offering is compelling enough to capture a slice of this market.

"Combining iMedNet's industry-leading technology with its pay-as-you-go, SaaS pricing model will significantly lessen the administrative burden and costs traditionally associated with EDC solutions​", explained John Robertson, president and CEO of MedNet.

The cost-benefits are similar to those associated with other SaaS platforms, such as reduced infrastructure expenditure and maintenance, and consequently iMedNet will succeed or fail on the strength of the technology.

iMedNet uses a ‘drag and drop’ interface to allow the user to set up forms, business logic, workflows and protocols using a reusable component library. Adopting this platform can cut the time for study creation and deployment to “a matter of days​”, according to MedNet.

Users can access the system through any internet-connected PC. MedNet believes its system is secure, an important factor for contract research organisations (CRO) and pharmas using SaaS.

Study administrators, data managers and monitors, investigators, research coordinators and patients can all be granted access to the system. Currently the system is in beta-testing and will be available for preview at the eClinical Technology Summit in Orlando, Florida, US in April.

iMedNet is currently scheduled for general release in the third quarter of 2010. The system is designed to be used at any stage of clinical trials, from Phase I through to post-marketing.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more